Description

(±)-1-[(3Ar*,4S*,9Bs*)-4-(6-Bromo-1,3-Benzodioxol-5-Yl)-3A,4,5,9B-Tetrahydro-3H-Cyclopenta[C]Quinolin-8-Yl]-Ethanone is a high-purity, advanced pharmaceutical intermediate featuring a complex, multi-cyclic molecular architecture. This compound is of significant value for its role as a key synthetic building block in the research and development of novel therapeutic agents. It is primarily sought after by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in medicinal chemistry and process development.

Application

This specialized intermediate is designed for advanced synthetic applications, particularly in the pharmaceutical sector.

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of potential drug candidates, especially those targeting central nervous system (CNS) disorders.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies to explore and optimize biological activity by modifying the core scaffold.
• Process Chemistry Development: Employed in scaling up synthetic routes from laboratory to pilot plant scale for preclinical and clinical trial material production.
• Reference Standard: Can be utilized as an analytical standard for method development and quality control in the production of related active pharmaceutical ingredients (APIs).
• Library Synthesis: A valuable building block for creating diverse chemical libraries for high-throughput screening in drug discovery programs.

Basic Information

Product Name	(±)-1-[(3Ar*,4S*,9Bs*)-4-(6-Bromo-1,3-Benzodioxol-5-Yl)-3A,4,5,9B-Tetrahydro-3H-Cyclopenta[C]Quinolin-8-Yl]-Ethanone
CAS No.	881639-98-1
Molecular Formula	C23H20BrNO3
Molecular Weight	438.32 g/mol
Synonyms	1-(4-(6-Bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl)ethanone; 8-Acetyl-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline; (±)-8-Acetyl-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline; CAS 881639-98-1; 881639-98-1
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to strict quality management systems. Every batch undergoes comprehensive analytical characterization to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing results from HPLC, NMR, and mass spectrometry are provided to support your R&D and regulatory documentation needs. We are committed to meeting the exacting standards required for pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) in a dry, well-ventilated area. Keep the container sealed to protect from moisture.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Residual Solvents (GC)	Meets ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.